Establishes the sickle cell disease education and mapping program to promote the screening and detection of sickle cell disease, educate the public regarding sickle cell disease, provide counseling and referral services and map locations of occurrence of sickle cell disease.
This bill would amend the Public Health Law to authorize the Commissioner of Health to create a statewide sickle cell disease education and mapping program. The program is intended to promote screening and detection of sickle cell disease, increase public education, provide counseling and referral services, and identify where cases occur across the state.
The bill defines “approved organizations” that may participate in the program, including hospitals, health maintenance organizations, organizations with sickle cell expertise, county or city health departments, or combinations of these entities. The Department of Health would be required to adopt regulations for a public education and outreach campaign, compile and publish data on the frequency of sickle cell disease by location, consult with approved organizations about local screening and referral services, and use the collected information to support health care education programs focused on diagnosis and treatment.
If enacted, the bill would create a new section of the Public Health Law and give the Department of Health explicit authority to collect, analyze, and publicly disseminate geographic data on sickle cell disease occurrence. It would also expand the department’s role in coordinating education, screening awareness, counseling, and referral pathways through hospitals, health plans, local health departments, and other approved organizations. The measure would affect public health administration, data reporting, and outreach efforts related to sickle cell disease, but it does not itself mandate treatment coverage or create a direct benefit entitlement.
The bill appears to be positively framed as a public health and awareness measure, with a focus on improving detection, education, and access to information for affected communities. Because there are no recorded committee transcripts or votes in the provided materials, there is no evidence of formal opposition or support beyond the bill’s stated purpose. The overall tone of the proposal suggests a preventive, service-oriented approach rather than a controversial policy change.
The main potential points of contention are likely to involve the collection and public posting of disease prevalence data, including privacy concerns, data accuracy, and how granular location-based mapping would be. There may also be questions about administrative burden on the Department of Health and participating organizations, as well as whether the bill should include funding or clearer implementation standards. No specific opponents or supporters are identified in the provided record, so these concerns are inferred from the bill’s structure rather than from recorded debate.